Info message
Dieser Inhalt ist nicht auf Deutsch verfügbar.Scientific Highlights
IPW Young Investigator Award 2022
Dr. Francesca Borgna, former Marie Curie Fellow at the Center for Radiopharmaceutical Sciences awarded by the Institute of Pharmaceutical Sciences in 2022 and gave the IPW Young Scientist lecture entitled: "Combination of Terbium-161 with Somatostatin Receptor Antagonists: a Potential Paradigm Shift for the Treatment of Neuroendocrine Neoplasm.
Poster Prize 2022: First Prize (AKB Foundation) of the SAPhW Poster Award at the Swiss Pharma Science Day 2022
Rahel Wallimann, PhD student in the “Nuclide Chemistry Group”, received the first prize (AKB Foundation) of the SAPhW Poster Award at the Swiss Pharma Science Day 2022.
NMB/Eckelman Young Investigator Award 2022
Chiara Favaretto, PhD student in the “Radionuclide Development” group at the Center for Radiopharmaceutical Sciences, received the NMB/Eckelman Young Investigator Award for the abstract entitled: “Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging”, presented at the International Symposium on Radiopharmaceutical Sciences (iSRS 2022).
Terbium Triumph
Bench-to-bedside successes: Fruitful collaborations at PSI’s Center for Radiopharmaceutical Sciences make bringing Terbium-161 to the clinic a reality.
Effective combination cancer treatment
Combining two chemotherapeutic drugs inhibits tumour growth.